Table 2.
Population |
Measurements |
Intrarater |
Interrater |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | N | Healthy/ symptomatic | Age (years) | Active/ Passive | Fl | Ex | Pro | Sup | CA | Trials (n) | Interval | Raters (n) | Expert/ non-expert |
Armstrong et al.21 | 38 | Symptomatic | N/A | Active | + | + | + | + | − | 2 | Same day | 5 | Both |
Blonna et al.15 | 50 | Both | 18–85 | Active | + | + | − | − | − | N/A | N/A | 4 | Both |
Chapleau et al.6 | 51 | Healthy | 19–50 | Active | + | + | − | − | + | 3 | Consecutively | 2 | N/A |
Cimatti et al.30 | 33 | Both | 18–70 | Active | − | − | + | + | − | 3 | Consecutively | 2 | Expert |
Fieseler et al.3 | 47 | Healthy | 18–25 | Active | + | + | − | − | − | 3 | Week | N/A | N/A |
Flowers et al.31 | 30 | Symptomatic | 21–79 | Passive | − | − | + | + | − | 2 | Same day | 3 | Expert |
Gajdosik32 | 31 | Healthy | 19–40 | Active | − | − | + | + | − | 3 | Consecutively | 1 | N/A |
Goodwin et al.33 | 23 | Healthy | 18–31 | Active | + | + | − | − | − | 2 | Month | 3 | Expert |
Low34 | 1 | Healthy | N/A | Active | + | − | − | − | − | N/A | N/A | 50 | Expert |
Petherick et al.35 | 30 | Healthy | 20–28 | Active | + | + | − | − | − | 3 | Consecutively | 2 | N/A |
Rothstein et al.36 | 12 | Symptomatic | N/A | Passive | + | + | − | − | − | 2 | Same day | 12 | Expert |
Zwerus7 | 30 | Healthy | 18–79 | Both | + | + | + | + | − | 2 | Week | 2 | Expert |
Total | 376 | 9 | 8 | 5 | 5 | 1 | 25 | 86 |
CA: Carrying Angle.